·Confidence 90%
Braveheart Bio Surges 68% Following $383 Million IPO
Key takeaways
- Braveheart Bio's shares soared 68% in their trading debut, reflecting strong investor interest in biotech despite concerns over high valuations and lack of
Analysis
Braveheart Bio's shares soared 68% in their trading debut, reflecting strong investor interest in biotech despite concerns over high valuations and lack of
0 likes · 0 dislikes